Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2013
11/06/2013EP2658399A1 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
11/06/2013EP2658374A1 Hepatoprotectant activity of garcinol
11/06/2013EP2658372A2 Matrix type antimicrobial vehicle and manufacturing method thereof
11/06/2013EP2471804B1 Diadenosine antibacterial compounds
11/06/2013EP2284266B1 siRNA targeting tp53
11/06/2013EP1854454B1 Method for the preparation of amorphous telmisartan
11/06/2013CN203263805U Resin container filled with antifungal drug composition
11/06/2013CN1968687B Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyacrylate derivatives
11/06/2013CN1856572B Use of RNAi inhibiting PARP activtiy for the manufacture of a medicament for the treatment of cancer
11/06/2013CN103384672A N-substituted oxazinopteridines and oxazinopteridinones
11/06/2013CN103384670A Substituted imidazo[1,2-b]pyridazines
11/06/2013CN103384669A Bicyclic inhibitors of ALK
11/06/2013CN103384668A Novel compounds and compositions for the inhibition of NAMPT
11/06/2013CN103384667A Benzoxazepines asn inhibitors of P13k/mTOR and methods of their use and manufacture
11/06/2013CN103384666A Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea
11/06/2013CN103384664A Anti-viral compounds
11/06/2013CN103384663A Synthesis of intermediates for preparing anacetrapib and derivatives thereof
11/06/2013CN103384662A Novel 1,2-bis-sulfonamide derivatives as chemokine receptor modulators
11/06/2013CN103384661A Mineralocorticoid receptor antagonists
11/06/2013CN103384659A Thioamide compound, method for producing thioamide compound, method for producing [(4r,6r)-6-aminoethyl-1,3-dioxane-4-yl]acetate derivative, and method for producing atorvastatin
11/06/2013CN103384533A Medicated patch for improved transdermal permeation of diclofenac diethylammonium
11/06/2013CN103384525A Human milk oligosaccharides for modulating inflammation
11/06/2013CN103384524A Methods for controlling pain in canines using a transdermal solution of fentanyl
11/06/2013CN103384523A Use of nifuratel to treat infections caused by clostridium species
11/06/2013CN103384522A Caffeic acid derivatives and their use in improving neuronal cell viability
11/06/2013CN103384521A Methods and compositions for preventing and treating osteoarthritis
11/06/2013CN103384520A Combination of components for the prevention and treatment of frailty
11/06/2013CN103384519A Anti-microbial composition
11/06/2013CN103384518A Novel antifungal composition
11/06/2013CN103384516A Formulations comprising polyethylene glycol
11/06/2013CN103384514A Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
11/06/2013CN103384513A Nasal compositions of vitamin B12
11/06/2013CN103382229A Preparation method and structural identification for novel strongylocentrotus nudus egg polysaccharide having immunoregulation effect
11/06/2013CN103382214A Tanshinone IIA phosphate phenolic ester derivative and preparation process thereof
11/06/2013CN103382213A 17-(2', 5'-disubstituted oxazolyl)-androstane-4, 16-diene-3-ketone, and preparation method and applications thereof
11/06/2013CN103382211A Structure and preparation method of morpholine modified silico-molybdate compound
11/06/2013CN103382207A Methylbenzofuran quinoline derivative, preparation method thereof, and application of derivative as antitumor drug
11/06/2013CN103382206A Quinoline or quinazoline derivative, its preparation method and application in medicines
11/06/2013CN103382205A Bone-targeting zinc phthalocyanine and its preparation method and use
11/06/2013CN103382203A Puerarin derivative and synthetic method and application thereof
11/06/2013CN103382201A Heteroaryl derivatives as cftr modulators
11/06/2013CN103382197A N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same
11/06/2013CN103382196A (E)-1-(8-benzopyranyl)-2-allyl-1-one and its analogues, and use thereof
11/06/2013CN103382195A Benzopyran chalcone compound, and preparation method and application thereof
11/06/2013CN103382190A Thiazole-cyclohexane compound of same category and preparation method and purpose thereof
11/06/2013CN103382183A Polymorph of 4-aniline quinazoline derivative, its preparation method and application
11/06/2013CN103382182A Phenylurea coupling quinazoline compound, and preparation method, pharmaceutical composition and pharmaceutical use thereof
11/06/2013CN103382177A Roflumilast N-oxide polymorphs and their preparation methods and pharmaceutical composition
11/06/2013CN103382176A Novel vanilloid receptor ligands and their use for producing medicaments
11/06/2013CN103382174A Cyclopropyl amine derivatives as histamin h3 receptor modulators
11/06/2013CN103381273A Doxorubicin prodrug, its preparation method and injectable composition
11/06/2013CN103381272A Method for improving levodropropizine taste by cyclodextrin clathration
11/06/2013CN103381271A Triazol compounds for treating biofilm formation
11/06/2013CN103381270A Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction
11/06/2013CN103381269A Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents
11/06/2013CN103381268A Solid pharmaceutical composition including proton pump inhibitor
11/06/2013CN103381259A Externally used Chinese patent medicine for treating soft tissue injury
11/06/2013CN103381231A Pain-killing paste for bone illness
11/06/2013CN103381228A Indoor humidifying fragrant liquid
11/06/2013CN103381227A External liniment and internal traditional Chinese medicine preparation formula for alopecia treatment
11/06/2013CN103381225A Compound pearl powder
11/06/2013CN103381223A Medicament for treating epilepsy
11/06/2013CN103381204A Leucoderma medicament and preparation method thereof
11/06/2013CN103381199A Traditional Chinese medicine for treating insomnia
11/06/2013CN103381197A Externally applied liniment used for treating alopecia seborrhoeica
11/06/2013CN103381196A Composition used for treating cervical erosion and application thereof
11/06/2013CN103381195A Fat emulsion injection and preparation method thereof
11/06/2013CN103381194A Drug for treating cough and preparation method thereof
11/06/2013CN103381189A Porous hemostatic powder and its preparation method
11/06/2013CN103381188A Application of Houttuynoid B in drug for treating atherosclerosis
11/06/2013CN103381187A Application of Houttuynoid E in drug for resisting platelet aggregation
11/06/2013CN103381186A Application of Houttuynoid A in vascular dilation drug
11/06/2013CN103381185A Application of Houttuynoid D in vascular dilation drug
11/06/2013CN103381184A Application of Houttuynoid C in anti-hypoxia drug
11/06/2013CN103381183A Application of Houttuynoid B in anti-hypoxia drug
11/06/2013CN103381182A Application of Houttuynoid C in drug for treatment of myocardial ischemia
11/06/2013CN103381181A Application of Houttuynoid D in anti-hypoxia drug
11/06/2013CN103381180A Application of Houttuynoid E in drug for treating or preventing chronic heart failure
11/06/2013CN103381179A Application of Houttuynoid D in drug for treating ischemic brain injury
11/06/2013CN103381178A Application of Houttuynoid D in drug for treatment of myocardial ischemia
11/06/2013CN103381177A Application of Houttuynoid B in drug for treating ischemic brain injury
11/06/2013CN103381176A Application of Houttuynoid C in drug for treating atherosclerosis
11/06/2013CN103381175A Application of Houttuynoid B in drug for resisting platelet aggregation
11/06/2013CN103381174A Application of Houttuynoid E in drug for treating ischemic brain injury
11/06/2013CN103381173A Application of Kudingcha saponin D in preparation of pharmaceuticals
11/06/2013CN103381172A Glycerophospholipids containing omega-3 and omega-6 fatty acids
11/06/2013CN103381171A Applications of Chukrasone A in medicines used for treating rheumatoid arthritis
11/06/2013CN103381170A Applications of Chukrasone A in preparation of anti-platelet aggregation medicines
11/06/2013CN103381169A Applications of Chukrasone A in anti-tubercle bacillus medicines
11/06/2013CN103381168A Applications of Chukrasone A in antidepressant medicines
11/06/2013CN103381167A Applications of Chukrasone A in medicines used for preventing pancreatic fibrosis
11/06/2013CN103381166A Applications of Chukrasone A in medicines used for treating or preventing acute heart failure
11/06/2013CN103381165A Applications of Chukrasone A in anti-helicobacter pylori medicines
11/06/2013CN103381164A Applications of Chukrasone A in antibacterial medicines
11/06/2013CN103381163A Applications of Chukrasone A in medicines used for treating acute gout
11/06/2013CN103381162A Applications of Chukrasone A in medicines used for treating dengue virus infection
11/06/2013CN103381161A Application of compound SC-51089 to prepare medicaments for treating diabetes and complications
11/06/2013CN103381160A Applications of Chukrasone B in medicines used for curing or preventing oral ulcer
11/06/2013CN103381159A Applications of Chukrasone B in medicines used for treating or preventing renal fibrosis
11/06/2013CN103381158A Applications of Chukrasone B in medicines used for increasing thrombocyte
1 ... 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 ... 7860